AGIO:NASDAQ
Agios Pharmaceuticals Inc
$33.47
arrow_upward
+0.51%(+0.17) 1D
Set 30, 3:06:21 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa AGIO...
Buksan
$33.67
Mataas
$34.06
Mababa
$33.20
Mkt. cap
2.00B
Avg. na dami
923.95K
Dami
247.29K
Mataas nang 52-wk
$45.99
Mababa nang 52-wk
$22.24
EPS
-$7.01
Beta
0.60
Mga natitirang share
59.70M
Bilang ng mga empleyado
540
Buksan
$33.67
Mataas
$34.06
Mababa
$33.20
Mkt. cap
2.00B
Avg. na dami
923.95K
Dami
247.29K
Mataas nang 52-wk
$45.99
Mababa nang 52-wk
$22.24
EPS
-$7.01
Beta
0.60
Mga natitirang share
59.70M
Bilang ng mga empleyado
540
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Benzinga
·
1 araw ang nakalipas
10 Health Care Stocks Whale Activity In Today’s Session
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Tungkol sa Agios Pharmaceuticals Inc